Omega Protein Corp. (OME) was one of the Russell 2000's biggest losers for Monday January 04 as the stock slid 6.85% to $20.68, a loss of $-1.52 per share. Starting at an opening price of $21.85 a share, the stock traded between $20.67 and $22.17 over the course of the trading day. Volume was 302,434 shares over 2,730 trades, against an average daily volume of 303,319 shares and a total float of 22.25 million.
The losses send Omega Protein Corp. down to a market cap of $460.05 million. In the last year, Omega Protein Corp. has traded between $25.22 and $10.25, and its 50-day SMA is currently $21.61 and 200-day SMA is $16.44.
The stock has a P/E Ratio of 20.2.
Omega Protein Corp is a nutritional ingredient company. It develops, produces and delivers healthy products throughout the world to improve nutritional integrity of foods, dietary supplements and animal feeds.
Omega Protein Corp. is based out of Houston, TX and has some 657 employees. Its CEO is Bret Scholtes.
For a complete fundamental analysis analysis of Omega Protein Corp., check out Equities.com’s Stock Valuation Analysis report for OME. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer